Salamone Ann Beal 4

What Happened

• Salamone Ann Beal, a director of Sanara MedTech, received a grant of 4,154 restricted shares on June 4, 2026. The Form 4 reports an acquisition at $0.00 per share (transaction code A), so the filing shows $0 as the reported transaction value. This is an equity award (compensation/award), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-04 (reported on Form 4 filed 2026-06-05)
• Price: $0.00 per share; reported transaction value $0
• Shares granted: 4,154 restricted shares
• Shares owned after transaction: not specified in the provided filing excerpt
• Footnote: Shares vest on the earlier of (i) the 2027 annual shareholder meeting or (ii) June 4, 2027, provided the reporting person continues providing certain services to the issuer
• Filing timeliness: Filed one day after the transaction (timely)

Context

• Restricted stock grants to directors are a common form of compensation and are subject to vesting conditions; they do not represent an immediate cash investment or sale. Because this is an award rather than a purchase or sale, it should not be interpreted as a direct bullish or bearish market signal.